 Sabrina Spencer
Concepts (178)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cell Cycle | 20 | 2025 | 604 | 4.880 |
Why?
| | Cyclin-Dependent Kinase 2 | 11 | 2025 | 39 | 3.770 |
Why?
| | DNA Replication | 5 | 2024 | 242 | 1.650 |
Why?
| | Cell Cycle Proteins | 5 | 2023 | 614 | 1.600 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 8 | 2025 | 121 | 1.530 |
Why?
| | Cyclin-Dependent Kinases | 5 | 2025 | 132 | 1.430 |
Why?
| | Cell Proliferation | 10 | 2025 | 2482 | 1.390 |
Why?
| | Cellular Senescence | 2 | 2023 | 188 | 1.280 |
Why?
| | Histones | 3 | 2024 | 641 | 1.210 |
Why?
| | MAP Kinase Signaling System | 3 | 2025 | 322 | 1.200 |
Why?
| | Cyclin D1 | 2 | 2025 | 67 | 1.090 |
Why?
| | Proto-Oncogene Proteins B-raf | 3 | 2025 | 227 | 1.090 |
Why?
| | Melanoma | 2 | 2025 | 758 | 1.020 |
Why?
| | Retinoblastoma Protein | 4 | 2025 | 57 | 0.970 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 2 | 2025 | 170 | 0.920 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 1 | 2025 | 125 | 0.910 |
Why?
| | CDC2-CDC28 Kinases | 1 | 2023 | 20 | 0.860 |
Why?
| | Signal Transduction | 10 | 2025 | 5096 | 0.860 |
Why?
| | Cyclin E | 1 | 2023 | 25 | 0.840 |
Why?
| | Single-Cell Analysis | 6 | 2024 | 309 | 0.830 |
Why?
| | Mitosis | 4 | 2024 | 193 | 0.760 |
Why?
| | DNA Damage | 3 | 2024 | 420 | 0.740 |
Why?
| | Models, Biological | 7 | 2018 | 1775 | 0.700 |
Why?
| | Mitogens | 2 | 2020 | 61 | 0.690 |
Why?
| | Cell Tracking | 1 | 2020 | 17 | 0.680 |
Why?
| | Time-Lapse Imaging | 1 | 2020 | 21 | 0.680 |
Why?
| | Neoplasms | 4 | 2023 | 2666 | 0.670 |
Why?
| | G2 Phase | 1 | 2020 | 38 | 0.670 |
Why?
| | G1 Phase | 1 | 2020 | 71 | 0.660 |
Why?
| | Cell Line, Tumor | 9 | 2025 | 3420 | 0.620 |
Why?
| | Cell Survival | 5 | 2025 | 1122 | 0.620 |
Why?
| | Microscopy, Fluorescence | 1 | 2020 | 402 | 0.600 |
Why?
| | Protein Kinase Inhibitors | 2 | 2023 | 920 | 0.590 |
Why?
| | Ki-67 Antigen | 1 | 2018 | 112 | 0.580 |
Why?
| | Proteolysis | 1 | 2018 | 180 | 0.560 |
Why?
| | Oncogene Proteins | 1 | 2017 | 59 | 0.550 |
Why?
| | TNF-Related Apoptosis-Inducing Ligand | 5 | 2013 | 51 | 0.550 |
Why?
| | Cell Line | 9 | 2025 | 2852 | 0.540 |
Why?
| | Cell Division | 5 | 2023 | 795 | 0.520 |
Why?
| | Neuroblastoma | 1 | 2017 | 161 | 0.510 |
Why?
| | Apoptosis | 5 | 2013 | 2557 | 0.490 |
Why?
| | Stem Cells | 1 | 2020 | 589 | 0.480 |
Why?
| | DNA | 2 | 2023 | 1460 | 0.480 |
Why?
| | Stress, Physiological | 2 | 2025 | 445 | 0.470 |
Why?
| | S Phase | 2 | 2024 | 78 | 0.430 |
Why?
| | Cell Transformation, Neoplastic | 2 | 2006 | 328 | 0.410 |
Why?
| | Gene Expression Regulation | 2 | 2025 | 2615 | 0.400 |
Why?
| | Algorithms | 1 | 2020 | 1702 | 0.390 |
Why?
| | Hydrogels | 3 | 2025 | 675 | 0.390 |
Why?
| | Breast Neoplasms | 1 | 2024 | 2249 | 0.360 |
Why?
| | Humans | 33 | 2025 | 137514 | 0.350 |
Why?
| | Polyethylene Glycols | 3 | 2025 | 640 | 0.340 |
Why?
| | Up-Regulation | 2 | 2021 | 846 | 0.290 |
Why?
| | Drug Resistance, Neoplasm | 3 | 2025 | 806 | 0.280 |
Why?
| | Neovascularization, Pathologic | 2 | 2006 | 301 | 0.280 |
Why?
| | Fluorescence Resonance Energy Transfer | 2 | 2025 | 177 | 0.280 |
Why?
| | Cell Cycle Checkpoints | 2 | 2024 | 98 | 0.260 |
Why?
| | Phosphorylation | 4 | 2025 | 1762 | 0.260 |
Why?
| | Tumor Suppressor Protein p53 | 2 | 2024 | 531 | 0.250 |
Why?
| | Caspases | 4 | 2013 | 247 | 0.250 |
Why?
| | Nuclear Proteins | 2 | 2023 | 710 | 0.240 |
Why?
| | Carbonates | 1 | 2025 | 10 | 0.240 |
Why?
| | Transcription Factor TFIIH | 1 | 2025 | 37 | 0.230 |
Why?
| | Carbamates | 1 | 2025 | 49 | 0.230 |
Why?
| | Esters | 1 | 2025 | 77 | 0.230 |
Why?
| | Systems Biology | 1 | 2004 | 66 | 0.220 |
Why?
| | Cyclin-Dependent Kinase 4 | 1 | 2024 | 47 | 0.210 |
Why?
| | Cell Differentiation | 3 | 2021 | 1979 | 0.210 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2024 | 106 | 0.210 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2023 | 75 | 0.210 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2025 | 283 | 0.210 |
Why?
| | Models, Genetic | 1 | 2006 | 607 | 0.210 |
Why?
| | Chromatin | 2 | 2024 | 524 | 0.210 |
Why?
| | Leucine | 1 | 2023 | 111 | 0.210 |
Why?
| | Neoplasm Proteins | 1 | 2006 | 433 | 0.210 |
Why?
| | Lysine | 2 | 2023 | 297 | 0.200 |
Why?
| | Methionine | 1 | 2023 | 159 | 0.200 |
Why?
| | Feedback | 1 | 2023 | 174 | 0.200 |
Why?
| | Gene Regulatory Networks | 1 | 2025 | 308 | 0.190 |
Why?
| | Oncogenes | 1 | 2023 | 117 | 0.190 |
Why?
| | Evolution, Molecular | 1 | 2006 | 488 | 0.190 |
Why?
| | Azides | 1 | 2022 | 46 | 0.190 |
Why?
| | Transcription Factors | 3 | 2025 | 1717 | 0.190 |
Why?
| | Cell Lineage | 2 | 2021 | 346 | 0.190 |
Why?
| | RNA Polymerase II | 1 | 2025 | 324 | 0.190 |
Why?
| | Receptors, Glucocorticoid | 1 | 2023 | 155 | 0.180 |
Why?
| | Mitochondrial Membranes | 3 | 2011 | 38 | 0.180 |
Why?
| | Activating Transcription Factor 4 | 1 | 2021 | 20 | 0.180 |
Why?
| | Research Report | 1 | 2021 | 83 | 0.180 |
Why?
| | Dexamethasone | 1 | 2023 | 377 | 0.170 |
Why?
| | Cellular Reprogramming | 1 | 2021 | 98 | 0.170 |
Why?
| | Embryonic Development | 1 | 2021 | 118 | 0.170 |
Why?
| | Cyclin D | 1 | 2020 | 9 | 0.170 |
Why?
| | Mutagenesis | 1 | 2021 | 182 | 0.170 |
Why?
| | Congresses as Topic | 1 | 2021 | 233 | 0.160 |
Why?
| | Amino Acids | 1 | 2023 | 503 | 0.160 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2020 | 134 | 0.160 |
Why?
| | Biosensing Techniques | 1 | 2020 | 127 | 0.160 |
Why?
| | Biomarkers | 2 | 2023 | 4172 | 0.150 |
Why?
| | MCF-7 Cells | 1 | 2018 | 127 | 0.140 |
Why?
| | Mutation | 3 | 2023 | 3964 | 0.140 |
Why?
| | Contact Inhibition | 1 | 2017 | 5 | 0.140 |
Why?
| | N-Myc Proto-Oncogene Protein | 1 | 2017 | 9 | 0.140 |
Why?
| | Cell Movement | 2 | 2020 | 972 | 0.140 |
Why?
| | Animals | 10 | 2023 | 37011 | 0.140 |
Why?
| | Protein Biosynthesis | 1 | 2020 | 434 | 0.140 |
Why?
| | Caenorhabditis elegans | 1 | 2020 | 307 | 0.140 |
Why?
| | Cdh1 Proteins | 1 | 2016 | 1 | 0.130 |
Why?
| | Anaphase-Promoting Complex-Cyclosome | 1 | 2016 | 5 | 0.130 |
Why?
| | Time Factors | 3 | 2020 | 6817 | 0.130 |
Why?
| | RNA, Messenger | 1 | 2023 | 2838 | 0.120 |
Why?
| | Myogenin | 1 | 2014 | 16 | 0.120 |
Why?
| | Transcriptome | 1 | 2021 | 974 | 0.110 |
Why?
| | 3T3 Cells | 1 | 2013 | 163 | 0.100 |
Why?
| | fas Receptor | 1 | 2013 | 95 | 0.100 |
Why?
| | Mice | 3 | 2023 | 17843 | 0.100 |
Why?
| | Permeability | 2 | 2009 | 162 | 0.090 |
Why?
| | Transcription, Genetic | 3 | 2025 | 1458 | 0.090 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2012 | 188 | 0.090 |
Why?
| | Mammals | 2 | 2023 | 286 | 0.090 |
Why?
| | HeLa Cells | 2 | 2009 | 640 | 0.080 |
Why?
| | Enzyme Activation | 2 | 2009 | 816 | 0.080 |
Why?
| | Pharmacological Phenomena | 1 | 2009 | 1 | 0.080 |
Why?
| | Cells | 1 | 2009 | 25 | 0.080 |
Why?
| | BH3 Interacting Domain Death Agonist Protein | 1 | 2009 | 11 | 0.080 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2012 | 1242 | 0.080 |
Why?
| | Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2009 | 30 | 0.080 |
Why?
| | Computer Simulation | 3 | 2012 | 986 | 0.080 |
Why?
| | Genes, Reporter | 1 | 2009 | 268 | 0.070 |
Why?
| | Probability | 1 | 2009 | 311 | 0.070 |
Why?
| | Adaptation, Physiological | 1 | 2012 | 546 | 0.070 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2013 | 1402 | 0.070 |
Why?
| | Promoter Regions, Genetic | 2 | 2025 | 1255 | 0.060 |
Why?
| | Cells, Cultured | 1 | 2013 | 4206 | 0.060 |
Why?
| | Computational Biology | 1 | 2010 | 645 | 0.060 |
Why?
| | Chromatin Assembly Factor-1 | 1 | 2024 | 12 | 0.060 |
Why?
| | Hydrolysis | 1 | 2025 | 191 | 0.060 |
Why?
| | Cryoelectron Microscopy | 1 | 2025 | 187 | 0.050 |
Why?
| | Alkynes | 1 | 2022 | 56 | 0.050 |
Why?
| | Feedback, Physiological | 2 | 2014 | 78 | 0.050 |
Why?
| | Transcriptional Activation | 1 | 2023 | 379 | 0.040 |
Why?
| | Binding Sites | 1 | 2023 | 1310 | 0.040 |
Why?
| | Epigenesis, Genetic | 1 | 2024 | 660 | 0.040 |
Why?
| | Glucocorticoids | 1 | 2023 | 599 | 0.040 |
Why?
| | Caenorhabditis elegans Proteins | 1 | 2020 | 198 | 0.040 |
Why?
| | Polymers | 1 | 2022 | 495 | 0.040 |
Why?
| | Proteomics | 1 | 2024 | 1113 | 0.040 |
Why?
| | RNA | 1 | 2023 | 924 | 0.030 |
Why?
| | F-Box Proteins | 1 | 2016 | 24 | 0.030 |
Why?
| | Female | 1 | 2024 | 73162 | 0.030 |
Why?
| | G1 Phase Cell Cycle Checkpoints | 1 | 2014 | 10 | 0.030 |
Why?
| | MyoD Protein | 1 | 2014 | 35 | 0.030 |
Why?
| | S-Phase Kinase-Associated Proteins | 1 | 2014 | 21 | 0.030 |
Why?
| | Bromodeoxyuridine | 1 | 2014 | 80 | 0.030 |
Why?
| | Molecular Imaging | 1 | 2014 | 55 | 0.030 |
Why?
| | Ubiquitination | 1 | 2014 | 104 | 0.030 |
Why?
| | Macrophages | 1 | 2021 | 1548 | 0.030 |
Why?
| | Stochastic Processes | 1 | 2013 | 71 | 0.030 |
Why?
| | Caspase Inhibitors | 1 | 2013 | 81 | 0.030 |
Why?
| | Phenotype | 2 | 2013 | 3205 | 0.020 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2014 | 379 | 0.020 |
Why?
| | Base Sequence | 1 | 2014 | 2180 | 0.020 |
Why?
| | Kinetics | 1 | 2014 | 1679 | 0.020 |
Why?
| | Antibodies, Neutralizing | 1 | 2013 | 282 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2014 | 2146 | 0.020 |
Why?
| | Drug Therapy | 1 | 2009 | 84 | 0.020 |
Why?
| | NF-kappa B | 1 | 2013 | 694 | 0.020 |
Why?
| | Apoptosomes | 1 | 2008 | 1 | 0.020 |
Why?
| | Caspase 8 | 1 | 2008 | 49 | 0.020 |
Why?
| | Organ Specificity | 1 | 2009 | 304 | 0.020 |
Why?
| | Caspase 9 | 1 | 2008 | 57 | 0.020 |
Why?
| | Cell Death | 1 | 2010 | 370 | 0.020 |
Why?
| | Protein Binding | 1 | 2014 | 2229 | 0.020 |
Why?
| | Caspase 3 | 1 | 2008 | 246 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2013 | 1770 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2014 | 1701 | 0.010 |
Why?
| | Proteins | 1 | 2009 | 1012 | 0.010 |
Why?
| | Inflammation | 1 | 2013 | 2837 | 0.010 |
Why?
|
|
Spencer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|